SCHEMBL10305185

SCHEMBL10305185

CCCCCCCC(=O)N[C@@H](C(=O)N1CCCC1)[C@@H](O)c1ccncc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UGCG Q16739 9/20 0.53
▸ ALDH1A1 P00352 1/20 0.50
▸ ASAH1 Q13510 1/20 0.50
▸ ACER2 Q5QJU3 1/20 0.50
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ MTOR P42345 1/20 0.45
▸ LMNA P02545 2/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.45
▸ GMNN O75496 1/20 0.45
▸ BLM P54132 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13374254 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL14305515 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL13375714 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL13374206 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL13375712 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL13374257 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL13374253 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL10305169 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
SCHEMBL10305130 1.00 UGCG (0.53) UGCGALDH1A1ASAH1ACER2MEN1
Hydrochloric Acid SCHEMBL4213303 0.99 UGCG (0.52) UGCGALDH1A1ASAH1ACER2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8927589-B2 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity ALLERGAN, INC. (US) 2015-01-06 — — US disclosed
US-8927589-B2 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity ALLERGAN, INC. (US) 2015-01-06 — — US disclosed
EP-2474534-A1 3-Aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity Allergan, Inc. (US) 2012-07-11 — — EP disclosed
WO-2008011478-A2 METHODS FOR TREATING CHRONIC PAIN USING 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS ALLERGAN, INC. (US) 2008-01-24 — — WO disclosed
Send feedback